Evidence map›Paper›PMID 37273634›Full record

ArticleACS omega2023

Facile Process for the Development of Antiviral Cotton Fabrics with Nano-Embossed Copper Oxide.

Fayyaz Salih Hussain, Najma Memon, Zeeshan Khatri

Abstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Engineering copper and copper-based materials for a post-antibiotic era.Frontiers in bioengineering and biotechnology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fayyaz Salih HussainNational Center of Excellence in Analytical Chemistry, University of Sindh, Jamshoro 76080, Sindh, Pakistan.
Najma MemonNational Center of Excellence in Analytical Chemistry, University of Sindh, Jamshoro 76080, Sindh, Pakistan.ORCID https://orcid.org/0000-0002-3241-8423
Zeeshan KhatriDepartment of Textile Engineering, Mehran University of Engineering and Technology, Jamshoro 76062, Pakistan.ORCID https://orcid.org/0000-0001-8779-3805

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metallic or metal oxide-based nanoparticles have the potential to inactivate viruses. Among various metals, copper has shown edge over others. One of the rapidly evolving areas is to combine nanoscience for production of self-sanitizing antiviral surfaces. In this study, we designed antiviral-coated fabrics to combat the spread of viruses. Copper oxide nanoparticles were sonochemically synthesized and subsequently deposited using the dip-coat process to modify the surface of fabric. The morphology and structure of uncoated and coated fabrics were examined by scanning electron microscopy, X-ray diffraction, FTIR, and elemental analysis. The findings show that small, agglomerated rugby ball structures made of copper oxide (CuO) nanoparticles (16 ± 1.6 nm, according to the Scherrer equation) develop on the surface of fabric, resulting in nano-embossing and a hydrophobic (contact angle > 140°) surface. The CuO-coated fabric yielded the maximum zone of inhibition for antibacterial activity. The virucidal activity (against human adenovirus-B) of CuO nanoparticle-fabricated fabric against adenovirus shows decreased 99.99% according to the ISO 18184 testing standard. With the dip and dry approach, any textile industry can use the simple coating procedure without having to change its textile operations. This fabric can be widely used in the face mask, clothing, bedding, and aprons, and the coating remains efficient over more than 25 washes.

Identifiers

PMID37273634
PMCPMC10233694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.